Pfizer Products Inc.

United States of America


 
Total IP 347
Total IP Rank # 3,693
IP Activity Score 0.4/5.0    1
IP Activity Rank # 936,820
Parent Entity Pfizer Inc.
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

4 0
10 41
219 0
73
 
Last Patent 2013 - Sulfonyl amide derivatives for t...
First Patent 1982 - Process for the accelerated soli...
Last Trademark 2024 - PFIZER IGNITE
First Trademark 1949 - PFIZER

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 G/S Contract manufacturing in the field of pharmaceuticals Pharmaceutical research and development; c...
2018 G/S Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes;...
G/S Pharmaceutical preparations for the prevention and treatment of psychiatric diseases, degenerativ...
2016 G/S A patient support and adherence program, namely providing a website offering education and resour...
G/S Custom manufacture of pharmaceutical preparations, pharmaceutical substances and pharmaceutical d...
2015 G/S Payment card services; debit card services; debit account services using a computer readable card...
G/S Downloadable software in the nature of a mobile application for providing information on health a...
2014 G/S Pharmaceutical preparations for the prevention and treatment of cardiovascular disease, gastroint...
G/S Pharmaceutical preparations for the treatment of cardiovascular disease, gastrointestinal disease...
2013 G/S Pharmaceutical preparations for the prevention and treatment of: cardiovascular disease; central ...
G/S Pharmaceutical preparations for the prevention and/or treatment of cardiovascular disease; centra...
2012 Invention Sulfonyl amide derivatives for the treatment of abnormal cell growth. The present invention relat...
Invention H) carbaldehyde derivatives. The present invention relates to compounds and pharmaceutically acce...
2010 G/S Pharmaceutical preparations for the treatment of cancer.
G/S Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
G/S Pharmaceutical preparations and substances. Medical apparatus and instruments.
2009 Invention Novel pyrazole compounds as transforming growth factor (tgf) inhibitors. Novel pyrazole compound...
G/S Pharmaceutical preparations for the prevention and/or treatment of: cardiovascular disease; centr...
G/S Antibiotic preparation for human use.
2008 Invention Dosage forms comprising celecoxib providing both rapid and sustained pain relief. A pharmaceutica...
Invention 1,4-dihydronaphthyridine derivatives. A compound of formulae (I) or a prodrug of the compound or ...
Invention Idarubicin for the treatment of lymphoma in a dog. The present invention relates to a metho...
Invention Idarubicin for the treatment of lymphoma in a dog. The present invention relates to a method of t...
Invention Multi-compartmented container. The invention provides a multi-compartmented container suitable fo...
Invention Polymorphs of prostaglandin agonists and methods for making the same. The present invention rela...
Invention Polymorphs of 3- ( ( (4-tert-butyl-benzyl) - (pyridine-3-sulfonyl) -amino) -methyl) -phenoxy) -ac...
Invention Polymorphs of (3-(((4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino)-methyl)- phenoxy)-acetic ac...
Invention 1, 3-oxazole derivatives as cetp inhibitors. Pharmaceutical compounds according to Formula I and ...
Invention 2-[2-(4,6-dihydroxy-tetrahydro-pyran-2-yl)ethyl]-isoindole-1,3-dione and related compounds.
Invention Process for preparing chiral compounds. The present invention is directed to a 2-deoxyribose-5-ph...
Invention Novel fused heteroaromatic compounds as transforming growth factor (tgf) inhibitors. Novel fused...
Invention Substituted bicyclolactam compounds. The invention provides compounds of formula (1), and the pha...
Invention Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers. A pharmaceutical co...
Invention Nanoparticles comprising a non-ionizable polymer and an anionic cellulosic polymer. A pharmaceuti...
Invention Thieno[2,3-d]pyrimidin-4(3h)-one, isoxazolo[5,4-d]pyrimidin-4(5h)-one and isothiazolo[5,4-d]pyrim...
Invention Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable bloc...
Invention Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene gly...
Invention Vaccine for periodontal disease. The present invention relates to novel bacterial isolates ident...
Invention Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polyme...
Invention Nanoparticles comprising a drug, ethylcellulose, and a bile salt. A pharmaceutical composition co...
Invention Pharmaceutical compositions comprising nanoparticles and casein. A pharmaceutical composition com...
Invention 3-amido-pyrrolo[3,4-c]pyrazole-5(1h,4h,6h) carbaldehyde derivatives. 8 are as defined above. The ...
Invention Nanoparticles comprising non-crystalline drug. A pharmaceutical composition comprises nanoparticl...
Invention Crystalline forms of 6- [2- (methylcarbamoyl) phenylsulfanyl] -3-e- [2- (pyridin-2-yl) ethenyl] i...
Invention Non-anaphylactogenic ige fusion proteins. The present invention provides compositions and method...
Invention Substituted oxadiazole analogs as calcium channel antagonists. This invention relates to novel co...
Invention Poly(adp-ribose) polymerases inhibitor for treating ophthalmic condition. This invention generall...
Invention Erythromycin-based macrolides. The invention relates to compounds of Formula (I) wherein R1, R2, ...
Invention Oxazolidinones as cholesterol absorption inhibitors. Novel oxazolidinones and pharmaceutical comp...
Invention Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 medi...
Invention Tricyclic compounds and their use as glucocorticoid receptor modulators. The present invention is...
Invention Tosylate salt of a therapeutic compound and pharmaceutical compositions thereof. The present inve...
2007 Invention Canine vaccines. This invention relates to vaccines and methods for protecting dogs against dise...
G/S Pharmaceutical preparation for the treatment of cardiovascular diseases.
Invention Compounds having both angiotensin ii receptor antagonism and ppary activating activities. Compou...
Invention Methods of vaccine administration. This invention relates to a method of treating a dog for canin...
G/S Pharmaceutical and veterinary preparations and substances.
G/S Sucker control agent for plants
G/S Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ...
Invention Gene predictors of response to metastatic colorectal chemotherapy. The present invention provide...
G/S Pharmaceutical and veterinary preparations and substances; sanitary preparations for medical purp...
Invention Aminophthalazine derivative compounds. The invention pertains to new aminophthalazine compounds ...
2006 Invention Pyrimidine derivatives for the treatment of abnormal cell growth. The present invention relates t...
G/S Pharmaceutical preparations that promote and enhance bone healing.
Invention Marked bovine viral diarrhea virus vaccines. The present invention is directed to a bovine viral...
G/S Printed materials, namely, booklets, brochures, leaflets and pamphlets related to smoking and smo...
Invention Therapeutic pyrrolidines. The present invention provides for compounds of Formula (I), The pre...
G/S Apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers,...
G/S Inhalers for administration of pharmaceutical preparations for human use with exception of pharma...
G/S Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes. Surgical,...
Invention 4-piperazinnylthieno[2,3-d]pyrimidine compounds as platelet aggregation inhibitors. Compounds an...
2005 G/S Pharmaceutical and veterinary preparations and substances; pharmaceutical preparations and substa...
Invention Dibenzyl amine compounds and derivatives. Dibenzyl amine compounds and derivatives, pharmaceutic...
Invention Compositions for the treatment of inflammation and pain using a combination of a cox-2 selective ...